2005
DOI: 10.1055/s-2005-919541
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of a new ataxia rating scale: Scale for the Assessment and Rating of Ataxia (SARA)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(16 citation statements)
references
References 0 publications
0
15
0
1
Order By: Relevance
“…However, we evaluate cerebellar cortex disordered disease, cerebellar nucleus disordered disease, and feed-back pathway disordered disease using the same evaluation scale. SARA is a scale constructed to assess various types of SCD [1]. Study of the natural course of SCD using SARA indicates that the type of SCD or the different repeat number results in a different deterioration rate [13].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, we evaluate cerebellar cortex disordered disease, cerebellar nucleus disordered disease, and feed-back pathway disordered disease using the same evaluation scale. SARA is a scale constructed to assess various types of SCD [1]. Study of the natural course of SCD using SARA indicates that the type of SCD or the different repeat number results in a different deterioration rate [13].…”
Section: Discussionmentioning
confidence: 99%
“…We evaluated the clinical severity of each patient in the SCD group using the Scale for the Assessment and Rating of Ataxia (SARA) [1,2] and the Berg Balance Scale (BBS) [3,4]. The mean SARA of the SCD group was 13.26±4.43, while the mean Unified Parkinson's Disease Rating Scale (UPDRS) part III was 18.48±8.4760.…”
Section: Subjectsmentioning
confidence: 99%
“…The scale was created in 1997 by the World Federation of Neurology Committee to provide a standardized clinical classification system to quantify deficits caused by cerebellar ataxia 11 . The ICARS has already been validated (English version) for evaluation of patients with multiple system atrophy and Parkinson's disease 23 , SCAs and Friedreich's ataxia 18,24,25 and focal cerebellar lesions 26 .…”
Section: Discussionmentioning
confidence: 99%
“…The use of the ICARS in clinical practice in patients with cerebellar ataxias has been criticized among professionals for being too long and having a great number of questions 27 . Indeed, Schmitz-Hubsch and coworkers 18 evaluated the metric properties of the ICARS. The scale was described as very long for application by the health professionals, with an average estimated time of 21 minutes.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation